Company’s 36-month beta value is 4.56.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for INBS is 6.66M, and currently, short sellers hold a 6.82% ratio of that floaft. The average trading volume of INBS on March 26, 2025 was 203.95K shares.
INBS) stock’s latest price update
Intelligent Bio Solutions Inc (NASDAQ: INBS)’s stock price has dropped by -16.59 in relation to previous closing price of 2.11. Nevertheless, the company has seen a loss of -16.98% in its stock price over the last five trading days. globenewswire.com reported 2025-03-25 that NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today provided shareholders with a status update on the FDA clearance process for its Intelligent Fingerprint Drug Screening System, which remains on track for launch in the U.S. in 2025 targeting its opiate test system for codeine, as validated in the Company’s Pharmacokinetic (PK) study. On December 18, 2024, the Company announced the submission of its 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for review and clearance of its Intelligent Fingerprinting Drug Screening System, which the FDA classified as a 21 CFR 862.3650, Opiate Test System, a Class II device requiring submission of a 510(k) premarket notification.
INBS’s Market Performance
Intelligent Bio Solutions Inc (INBS) has experienced a -16.98% fall in stock performance for the past week, with a -21.08% drop in the past month, and a 38.58% rise in the past quarter. The volatility ratio for the week is 14.21%, and the volatility levels for the past 30 days are at 10.83% for INBS. The simple moving average for the past 20 days is -17.65% for INBS’s stock, with a 5.32% simple moving average for the past 200 days.
INBS Trading at -9.51% from the 50-Day Moving Average
After a stumble in the market that brought INBS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -62.07% of loss for the given period.
Volatility was left at 10.83%, however, over the last 30 days, the volatility rate increased by 14.21%, as shares sank -11.56% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +32.33% upper at present.
During the last 5 trading sessions, INBS fell by -16.98%, which changed the moving average for the period of 200-days by -23.14% in comparison to the 20-day moving average, which settled at $2.14. In addition, Intelligent Bio Solutions Inc saw 25.71% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for INBS
Current profitability levels for the company are sitting at:
- -3.58 for the present operating margin
- 0.41 for the gross margin
The net margin for Intelligent Bio Solutions Inc stands at -3.53. The total capital return value is set at -2.53. Equity return is now at value -279.80, with -122.18 for asset returns.
Based on Intelligent Bio Solutions Inc (INBS), the company’s capital structure generated 0.13 points at debt to capital in total, while cash flow to debt ratio is standing at -16.17. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -81.46.
Currently, EBITDA for the company is -8.81 million with net debt to EBITDA at 0.16. When we switch over and look at the enterprise to sales, we see a ratio of 3.41. The receivables turnover for the company is 11.39for trailing twelve months and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.89.
Conclusion
In a nutshell, Intelligent Bio Solutions Inc (INBS) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
